HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giorgia Teresa Maniscalco Selected Research

Steroids

10/2021GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giorgia Teresa Maniscalco Research Topics

Disease

22Multiple Sclerosis
09/2022 - 01/2011
6Relapsing-Remitting Multiple Sclerosis
09/2022 - 01/2015
3COVID-19
06/2022 - 01/2022
3Progressive Multifocal Leukoencephalopathy
02/2022 - 01/2020
2Nervous System Diseases (Neurological Disorders)
07/2022 - 10/2021
2Infections
06/2022 - 01/2022
2Neoplasms (Cancer)
10/2021 - 11/2020
2Epilepsy (Aura)
10/2021 - 11/2020
2Sudden Infant Death (SID)
05/2021 - 01/2020
1Glioma (Gliomas)
07/2022
1Disease Progression
01/2022
1Cognitive Dysfunction
10/2021
1Cerebellar Ataxia (Dysmetria)
10/2021
1Melanoma (Melanoma, Malignant)
10/2021
1Stiff-Person Syndrome (Stiff Man Syndrome)
10/2021
1Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
10/2021
1Encephalitis (Encephalitis, Rasmussen)
04/2021
1Optic Neuritis (Retrobulbar Neuritis)
04/2021
1Starvation
01/2021
1Sarcoma (Soft Tissue Sarcoma)
11/2020
1Seizures (Absence Seizure)
11/2020
1Inflammation (Inflammations)
10/2019
1Overactive Urinary Bladder (Overactive Bladder)
01/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2015
1Autoimmune Diseases (Autoimmune Disease)
11/2015

Drug/Important Bio-Agent (IBA)

5Natalizumab (Tysabri)FDA Link
02/2022 - 01/2011
3COVID-19 VaccinesIBA
07/2022 - 01/2022
3Alemtuzumab (Campath)FDA Link
01/2022 - 10/2019
3Dronabinol (THC)FDA LinkGeneric
10/2020 - 01/2018
2Proteins (Proteins, Gene)FDA Link
07/2022 - 10/2019
2AntibodiesIBA
07/2022 - 04/2021
2VaccinesIBA
07/2022 - 02/2022
2mRNA VaccinesIBA
06/2022 - 02/2022
2CannabidiolIBA
10/2020 - 01/2020
2nabiximols (Sativex)IBA
01/2020 - 01/2017
1CladribineFDA LinkGeneric
09/2022
1AntigensIBA
07/2022
1Leucine (L-Leucine)FDA Link
07/2022
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
07/2022
1BNT162 VaccineIBA
06/2022
1Immunoglobulin G (IgG)IBA
06/2022
1ocrelizumabIBA
04/2022
1Monoclonal AntibodiesIBA
04/2022
1nitazoxanide (NTZ)FDA Link
02/2022
1Interferon beta-1aFDA Link
02/2022
1Messenger RNA (mRNA)IBA
01/2022
1Interferon-betaIBA
01/2022
1NivolumabIBA
10/2021
1Immune Checkpoint InhibitorsIBA
10/2021
1SteroidsIBA
10/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
07/2021
1Cytidine Diphosphate (CDP)IBA
01/2021
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2021
1Anticonvulsants (Antiepileptic Drugs)IBA
11/2020
1AutoantibodiesIBA
11/2020
1Pharmaceutical PreparationsIBA
10/2020
1GlucocorticoidsIBA
10/2019
1Annexin A1IBA
10/2019
1Fingolimod Hydrochloride (FTY720)FDA Link
10/2019
1InterferonsIBA
01/2016
1Interleukin-2 (IL2)IBA
11/2015
1Uric Acid (Urate)IBA
01/2015

Therapy/Procedure

8Therapeutics
06/2022 - 01/2020
3Injections
01/2021 - 01/2016
2Aftercare (After-Treatment)
10/2021 - 04/2021
1Immunotherapy
11/2020
1Radiotherapy
11/2020